OBJECTIVES
This study intended to identify an optimal target HbA1c range using real-world data (RWD) from electronic medical records (EMRs) in patients over 50 years of age with T2DM:
• How do hemoglobin A1c values correlate with glucose values, hypoglycemic events, and diabetic complications? • Is there an ideal target HbA1c value which can be recommended as the best balance between complications of diabetes and consequences of overtreatment, especially for the elderly? 
RESULTS
• 122,810 patients fulfilled the HbA1c stability criteria and could be stratified into one of the five strata. The majority of patients (62,330) had HbA1c values between 5.5 and 6.49% on two occasions at least 6 months apart from each other.
• 25,380 patients had HbA1c over 8.5%, and only 200 patients below 4.5%.
• With exception of the low HbA1c stratum (<4.5%), mean age, gender and concomitant hypertension did not differ significantly across the strata. (See Table 1 ).
• Median glucose values correlated well with HbA1c, from 110 mg/dL with HbA1c < 4.5% to 209 mg/dL with HbA1c > 8.5%.
• The incidence of hypoglycemic events were the highest in the two lowest HbA1c strata, indicative of a higher hypoglycemic risk if T2DM is "overtreated".
• The frequency of diabetic complications increased with HbA1c values above 6.5% as to be expected.
• Surprisingly, the lowest HbA1c stratum (<4.5%) showed a higher diabetic complication rate than the median strata (4.5 -6.5%), which could be contributed to "overtreated" severe cases or just a consequence of the low sample size in this stratum.
• Similarly, the percentage of patients on insulin showed a J-shaped curve, too, which may confirm the hypothesis of "overtreatment" of severe cases.
• However, the J-shape did not change when patients on insulin were removed from the cohort.
• Overall, patients in the HbA1c stratum of 5.5 -6.49% had the lowest risk of experiencing a hypoglycemic event and also the lowest diabetic complication rate (See Figure 4) . 
CONCLUSIONS
• Real-world data confirmed an excellent correlation between HbA1c and median glucose values.
• The data suggest a J-shaped curve with a range of HbA1c 5.5 -6.5 % displaying the lowest frequency of both, hypoglycemic events ("overtreatment") and diabetic complications.
• To our knowledge this is the first study proposing an optimal HbA1c treatment target for T2DM based on a large set of real-world data. 
